The Multicenter, Randomized, Double Blind Phase 3 Clinical Trial to Compare Efficacy and Safety of Combination of Amlodipine and Losartan Compared to Amlodipine Monotherapy in Patients With Stage 2 Hypertension

NCT01127217 Phase 3 COMPLETED

The purpose of this study is to evaluate the blood pressure lowering effects of an amlodipine/losartan combination treatment and amlodipine monotherapy for treatment of Stage 2 hypertensive patients.

Details

Lead sponsor	Hanmi Pharmaceutical Company Limited
Phase	Phase 3
Status	COMPLETED
Enrolment	149
Start date	2009-05
Completion	2010-03

Conditions

• Hypertension

Interventions

• amlodipine/losartan
• amlodipine

Primary outcomes

• Change from baseline in MSSBP — Baseline, Week 6

Countries

South Korea